u/Traditional_One_3580 — thesis ledger

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	1	1	1	100%	-12.5%	-12.5%
3d	1	1	1	100%	-8.8%	-8.8%
1w	1	1	1	100%	-14.7%	-14.7%
1m	1	1	1	100%	-39.0%	-39.0%
3m	0	0	0	—	—	—
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Window

Theses

Resolved

Wins

Win rate

Avg return

Median return

100%

-12.5%

100%

-8.8%

100%

-14.7%

100%

-39.0%

—

Thesis history

$BFRIr/pennystocksTechnical Analysisbearish

u/Traditional_One_3580 · 38d agono track record yet

“author bought BFRI stock (quantity not specified) ahead of FDA approval decision expected on or before 09/28/26”

BFRI FDA Approved - Down 11%

BFRI stock dropped 11% immediately after FDA approval of Ameluz for superficial basal cell carcinoma, despite strong Phase 3 trial data (66% complete clinical response vs 5% placebo, 83% complete clearance of all lesions vs 21%). The author expresses frustration at the counterintuitive market reaction to what appears to be positive regulatory news.

At post $1.36Now $0.81-40.3% since posted1m ago

1d-12.5%

3d-8.8%

1w-14.7%

1m-39.0%

3m—

6m—

1y—

original post →

End of results.